All published reports.

Senmiao Technology is a very high risk China ride-hailing auto-services microcap. The filings show a small post-disposal operating base, continuing losses, material weaknesses, Nasdaq compliance pressure and potentially heavy dilution mechanics.

AIG is now a focused global P&C underwriting and capital-return story. The latest filings show a 90.1 General Insurance combined ratio in 2025, an 87.3 combined ratio in Q1 2026, heavy buybacks, a smaller Corebridge stake and a live CEO transition.

AIFU still has a large China insurance distribution platform, with 42,170 registered agents and 313 sales outlets, but the 2025 Form 20-F shows a severe revenue and asset-quality reset before a 2026 acquisition added dark tea inventory, heavy share issuance and more governance questions.

Firefly Neuroscience pairs an FDA-cleared Evoke EEG/ERP workflow, more than 85 active U.S. clinical sites and a 191,000-record brain-data set with a harder financial reality: Q1 2026 revenue was only $485,000, cash was $3.1 million before subsequent financings, controls were ineffective and management disclosed substantial doubt about going concern.

AI Financial has a real ALT5 fintech platform with $24.8 million of FY2025 revenue and $3.5 billion of disclosed 2025 transaction volume, but its current equity story is dominated by WLFI token volatility, a $344.5 million net loss, a working-capital deficit, material weaknesses and a delayed Q1 filing.

Ambitions is a profitable Dubai MICE and tourism services operator with $20.2 million of fiscal 2025 revenue, but the public-equity case carries newly public issuer, founder-control, internal-control, cash-conversion and listing-risk watch items.

Akso Health Group is pitching an internet-healthcare pivot, but the latest filings show low-margin marketing-promotion revenue, nil interim medical-device revenue, a major impairment and a sharp cash shift into internet-hospital advances.

AdaptHealth raised 2026 revenue guidance after a major strategic partner rollout, but Q1 showed the cost of scale: elevated labor, negative free cash flow and a balance sheet that still needs refinancing execution.

Agilysys is posting record hospitality-software revenue while subscription revenue keeps outgrowing the total company. The decision point is whether a services-heavy implementation engine, Book4Time and a major PMS rollout can turn demand into durable recurring revenue.

Argan finished fiscal 2026 with record backlog, no debt and nearly $895 million of cash and investments. The AGX question is whether Power-heavy backlog converts into profitable revenue without project execution pain.

Axe Compute has signed a larger AI infrastructure story onto a tiny legacy revenue base, but the decisive proof is whether AGPU converts announced GPU contracts into recognized revenue and cash while ATH volatility sits on the balance sheet.

Assured Guaranty is a financial guaranty insurer with Q1 2026 new-business growth, record adjusted book value per share and a long buyback record, but the equity case still depends on ratings strength, insured-credit losses, PREPA and disciplined capital allocation.

eXp World Holdings is now trading as AGNT after adding NextHome's franchise model to its cloud brokerage platform, but the equity case still has to prove agent retention, gross-profit conversion and legal resilience.

AGNC is a leveraged Agency MBS mortgage REIT. Q1 2026 spread income covered the common dividend, but tangible book value fell and the common equity remains tied to mortgage spreads, repo funding, hedge performance and leverage.

Agenus has pushed BOT plus BAL into a global Phase 3 colorectal cancer trial and is generating early access revenue, but the current thesis is a race between regulatory progress and financing pressure: Q1 cash was $35.0M, operating cash flow was negative, the latest 10-Q carries going-concern language, and the products remain investigational.

Farmer Mac is compounding a record rural-credit book with strong spread income and capital headroom, but AGM holders own non-voting common in a highly levered GSE whose thesis depends on funding access, agricultural credit quality, policy treatment and disciplined capital allocation.

AGM.A is Farmer Mac's Class A voting common stock, with real board-election rights for eligible non-Farm Credit System financial institutions and the same declared common dividend as AGM, but ownership restrictions, narrow holder eligibility, related-party context and Farmer Mac's levered rural-credit model make it a specialized security.

agilon health turned in a stronger Q1 after a brutal FY2025 reset, but the thesis still depends on whether member exits, payor discipline, ACO contribution and CEO execution can hold up against Medicare Advantage medical-cost trend.

Abundia Global Impact Group is the renamed Houston American Energy, now pitching waste-plastics and biomass-to-fuels infrastructure. The filings show a Baytown site, licensed technology, fresh equity cash and an RPD related-party acquisition, but Renewables remains pre-revenue and the going-concern/control risks are still live.

Agencia Comercial Spirits Ltd came public as a Taiwan whisky importer, then disclosed a 2026 AI infrastructure pivot with a non-binding US$120M server LOI, a US$14.55M PIPE, Indonesian power commitments and a five-year services agreement that may represent up to US$374.4M in estimated gross service fees if deployment and customer acceptance conditions are met.

Allied still has HyperX Arena Las Vegas, Z-Tech mobile games, and a balance-sheet cushion, but the current thesis is about the late 10-K, Nasdaq delisting risk, reverse-split vote, Knighted settlement, and whether revenue can ever catch the cost base.

Aimei Health is no longer a healthcare-search story. It is a high-risk de-SPAC watch where a small remaining SPAC trust is trying to close a $1.5 billion all-share United Hydrogen transaction.

Advanced Flower Capital's first quarter as a BDC showed dividend-covering NII and higher NAV, but three nonaccrual loans still represented 36.6% of amortized cost and 23.5% of fair value.

AudioEye sits in a useful corner of software: websites and mobile apps keep needing accessibility testing, monitoring and remediation. The appeal is $41.2 million of ARR, about 78% GAAP gross margin and positive operating cash flow. The catch is that AEYE is still a small, levered company with GAAP losses, customer concentration and litigation expense.

Aeva has the kind of customer list lidar startups chase: Daimler Truck, a Top 10 European OEM, NVIDIA, Forterra, Nikon and smart-infrastructure deployments. The catch is that revenue is still $6.3 million a quarter, broad-based deliveries are not expected in 2026, and the bridge is funded by cash, convertible debt and an equity-linked facility.

Atlas Energy Solutions still depends on Permian completions, proppant volumes and the Dune Express. The new question is whether a 1.4 GW Caterpillar framework and a 120 MW tech-customer PPA can turn AESI into a power supplier before leverage, losses and execution risk catch up.

AES has a large clean-power and utility platform, but the March 2026 $15.00 cash merger agreement changes the public-equity question into a regulatory-close trade backed by a company-disclosed growth-capital problem.

Aeries has turned fiscal 2026 adjusted EBITDA positive and sells an AI-enabled GCC model to private-equity and middle-market clients, but the latest filings also show going-concern doubt, Nasdaq delisting proceedings, FPA obligations and control weaknesses.

Aeroméxico has premium demand, loyalty scale and record-margin evidence after its U.S. listing, but the Delta JCA, MEX constraints, fuel, FX, engine issues and a negative equity balance sheet make the setup high risk.

AerCap is using tight aircraft supply to produce record earnings, asset-sale gains and buybacks. The upside is real, but the model still runs on leverage, airline customer health and aircraft residual values.

AEP has turned the utility growth story into a transmission-led data-center and industrial load story, lifting its 2026-2030 capital plan to $78 billion while preserving 2026 guidance. The investment case now depends on rate recovery, balance-sheet funding and whether signed load becomes real demand.

AEO has a fast-growing Aerie franchise, a still-large American Eagle denim core, positive cash flow and no year-end long-term debt, but fiscal 2025 exposed how quickly tariffs, markdowns, leases, inventory and restructuring charges can shrink retail margins.

AENT is a profitable physical-media and collectibles distributor with more than $1 billion of annual revenue, improving margins, exclusive studio and label relationships, insider control and a balance sheet that depends on inventory, receivables and revolver availability behaving.

AEIS just put up 26% Q1 revenue growth, more than doubled Data Center Computing revenue, crossed a 40% non-GAAP gross-margin milestone, and priced $1.0 billion of 0% convertible notes. The upside is real; so are the customer, working-capital, and dilution questions.

Aehr Test just printed a $37.2 million bookings quarter tied to AI processors, silicon photonics, and hyperscale data-center infrastructure. The harder part is still ahead: turning that order rebound into revenue, margin recovery, and per-share value after a weak fiscal 2026 run rate.

Ameren is pitching a regulated-utility growth story built on $31.8 billion of 2026-2030 infrastructure investment, but the thesis has to clear rate cases, customer bills, equity funding, and large-load demand.

Aebi Schmidt is a newly enlarged specialty-vehicle platform with snowplows, municipal equipment, airport equipment, commercial truck bodies, Shyft merger synergies, a $1.3 billion backlog, and a leverage target that needs cash conversion.

Advanced Biomed has historical cancer-diagnostics technology, but the latest filings show no product revenue, a reverse split, a short-term loan, a subsidiary divestiture, and an April 2026 pivot into AI.

Advantage Solutions has national retail execution scale and positive adjusted EBITDA, but the equity case is hostage to Branded Services pressure, cash conversion, refinancing costs, and 4.2x net leverage.

Addus has profitable scale in home-based care, but the investment case turns on a narrow spread between reimbursement, wages, Illinois concentration, and acquisition discipline.

ADT has a 6.1 million-subscriber monitoring base, $359 million of recurring monthly revenue, and real cash generation, but the stock story now depends on whether ADT+, Origin AI, and smart-home intelligence can improve growth without stretching payback or leverage.

Autodesk has a $7.2 billion recurring software base, 97% recurring revenue, and a larger direct channel, but the next leg depends on whether AI, cloud platforms, and the transaction model expand the toll road without cracking margins or partner trust.

ADSE has battery-buffered charging technology and a service-led pivot, but 2025 revenue collapsed, the annual report is delayed, and the turnaround now depends on cash, capital structure, C&I execution, and recurring revenue.

ADP's payroll and HCM machine still looks durable, but the more interesting read-through is the mix of recurring workflow revenue, client-funds interest, and a PEO segment that can quietly dilute margin quality.

Adient has the footprint OEMs need and the revenue scale investors notice, but the stock case comes down to whether EMEA repair, Asia pricing, launch costs, tariffs, and working capital finally let margin catch up with sales.

ADM enters 2026 with raised guidance, stronger ethanol and Nutrition signals, and deep liquidity, but the first-time read has to balance those positives against weak 2025 segment profit, commodity timing, trade exposure, and still-live litigation.

ADI is not a pure AI stock. It is a cash-rich analog semiconductor leader where industrial recovery, automotive resilience, and data-center infrastructure orders are now arriving at the same time.

Adeia can look like a quiet licensing company until the moving parts show up: lumpy patent revenue, high margins, customer concentration, debt paydown, semiconductor wins, litigation, and a CEO search running through 2026.